{"id":791,"date":"2026-09-01T17:35:05","date_gmt":"2026-09-01T17:35:05","guid":{"rendered":"https:\/\/nhdbio.com\/resources\/melanotan-ii-human-pilot-toxicity-regulatory-evidence\/"},"modified":"2026-09-08T07:30:41","modified_gmt":"2026-09-08T07:30:41","slug":"melanotan-ii-daten-zur-toxizitat-aus-klinischen-pilotstudien-am-menschen-fur-zulassungszwecke","status":"publish","type":"post","link":"https:\/\/nhdbio.com\/de\/melanotan-ii-human-pilot-toxicity-regulatory-evidence\/","title":{"rendered":"Melanotan II: Daten von menschlichen Piloten, Toxizit\u00e4t und beh\u00f6rdlicher Status"},"content":{"rendered":"

Melanotan II verf\u00fcgt \u00fcber begrenzte Daten zur fr\u00fchen Exposition des Menschen und dokumentierte Sch\u00e4den durch unregulierte Verwendung. Ein dreik\u00f6pfiger Br\u00e4unungspilot kann sp\u00e4tere Toxizit\u00e4tsberichte oder aktuelle Warnungen der Aufsichtsbeh\u00f6rden nicht aufwiegen.<\/p>

Beweise auf einen Blick<\/h2>
  • Der 1996-Einfachblindpilot rekrutierte drei gesunde m\u00e4nnliche Freiwillige und verwendete abwechselnd Kochsalzl\u00f6sungs- oder Melanotan II-Tage.<\/li>
  • Bei 0.03 mg\/kg hatte einer von zwei Teilnehmern Schl\u00e4frigkeit und M\u00fcdigkeit des Grades II; Es wurde auch \u00fcber \u00dcbelkeit und anhaltende spontane Erektionen berichtet.<\/li>
  • Auf eine best\u00e4tigte 6 mg-Exposition bei einem 39 Jahre alten Mann folgten Tachykardie, Nierenfunktionsst\u00f6rung und ein Anstieg von CPK von 1,760 auf 17,773 IU\/L.<\/li><\/ul><\/div><\/div>
    \"Dokumentarische
    Von AI erstellte redaktionelle Illustration zur Veranschaulichung des Forschungsworkflows. Es handelt sich nicht um eine Studienfigur, ein Patientenbild, ein Produktfoto, ein Testergebnis oder ein Kataloglos.<\/figcaption><\/figure>

    Studienprotokoll<\/h2>

    Das Phase-I-Pilotprojekt war darauf ausgelegt, kurzfristige Auswirkungen zu beobachten und nicht die Sicherheit der Bev\u00f6lkerung zu gew\u00e4hrleisten. Drei Teilnehmer reichen nicht aus, um ungew\u00f6hnliche unerw\u00fcnschte Ereignisse einzusch\u00e4tzen, und das Ergebnis validiert die heutigen Internetprodukte nicht.<\/p>

    1996-Pilot<\/strong>3 gesunde M\u00e4nner; abwechselnd Kochsalzl\u00f6sung\/MT-II; 0.01 bis 0.025\u20130.03 mg\/kg<\/span><\/div>
    Pilotsignale<\/strong>Pigmentierung in 2; Es wurde \u00fcber \u00dcbelkeit, Schl\u00e4frigkeit\/M\u00fcdigkeit und Erektionen berichtet<\/span><\/div>
    2012-H\u00fclle<\/strong>39-j\u00e4hriger Mann; 6 mg im Internet gekauftes Material, best\u00e4tigt durch Massenspektrometrie<\/span><\/div>
    CPK-Spitzenwert<\/strong>17,773 IU\/L zu 12-Stunden<\/span><\/div>
    Regulierungsgrenze<\/strong>FDA beschreibt Melanotan II als ein nicht zugelassenes neues Medikament; TGA hat inkonsistente Online-Produktinhalte gefunden<\/span><\/div><\/div><\/div>

    Ergebnisse im Kontext<\/h2>

    Im Fall der 2012-Toxikologie erreichte die Herzfrequenz 146 Schl\u00e4ge pro Minute, der Kreatininwert betrug 2.25 mg\/dl, CPK erreichte sp\u00e4ter einen H\u00f6chstwert von 17,773 IU\/L und die Intensivbehandlung dauerte drei Tage. Die Massenspektrometrie best\u00e4tigte Melanotan II gegen\u00fcber einem Standard, was die Expositionszuordnung st\u00e4rkte, aber dennoch ein Einzelfall blieb.<\/p>

    Im August berichtete 2026, das australische Unternehmen TGA, dass f\u00fcnf beschlagnahmte Nasensprayflaschen mit der Aufschrift 30 mg gesch\u00e4tzte Mengen zwischen 22 und 54 mg enthielten. Diese Inkonsistenz in der Praxis stellt ein Risiko f\u00fcr Produktqualit\u00e4t und Dosierung dar, unabh\u00e4ngig von der Pharmakologie des Molek\u00fcls.<\/p>

    Was die Beweise nicht belegen k\u00f6nnen<\/h2>

    Die dreik\u00f6pfige Pilotstichprobe kann weder Sicherheit noch Wirksamkeit nachweisen.<\/p>

    Ein Fallbericht kann zwar keine Inzidenz absch\u00e4tzen, aber ein plausibles schwerwiegendes Ereignis dokumentieren.<\/p>

    Ein unregulierter Produktinhalt l\u00e4sst sich aus einem Etikett nicht ableiten und bei Katalogrecherchematerialien handelt es sich nicht um zugelassene Arzneimittel.<\/p>","protected":false},"excerpt":{"rendered":"

    Melanotan II verf\u00fcgt \u00fcber begrenzte Daten zur fr\u00fchen Exposition des Menschen und dokumentierte Sch\u00e4den durch unregulierte Verwendung. Ein dreik\u00f6pfiger Br\u00e4unungspilot kann sp\u00e4tere Toxizit\u00e4tsberichte oder aktuelle Warnungen der Aufsichtsbeh\u00f6rden nicht aufwiegen.<\/p>","protected":false},"author":1,"featured_media":775,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"pim_family_ids":"350","pim_article_type":"Published evidence review","pim_evidence_level":"Three-person phase I pilot, case reports and current regulatory safety warnings","pim_reviewer":"Site evidence editorial team","pim_reviewed_date":"2026-09-02","pim_editorial_note":"Source-checked on 2026-09-02. Null results, sample size, model\/population limits and regulatory scope are retained. This is not medical advice, a customer case or validation of a catalog lot.","pim_review_status":"reviewed","pim_review_reason":"Primary and official sources, numerical results, null findings, limitations, product-evidence boundary and image disclosure checked for batch 4.","pim_creation_method":"This article discusses the source records listed below, with the study models and limitations stated alongside the findings. AI-assisted drafting and image generation were used. The reference list identifies the records behind this article; it is not an independent peer review or verification of a supplied catalog lot.","pim_sources":"[{\"title\":\"Melanotan II pilot phase I study\",\"url\":\"https:\/\/pubmed.ncbi.nlm.nih.gov\/8637402\/\",\"note\":\"Three-person single-blind pilot; PMID 8637402.\"},{\"title\":\"Melanotan II systemic toxicity and rhabdomyolysis\",\"url\":\"https:\/\/pubmed.ncbi.nlm.nih.gov\/23121206\/\",\"note\":\"Mass-spectrometry-confirmed case report; PMID 23121206.\"},{\"title\":\"TGA finds inconsistent Melanotan II content\",\"url\":\"https:\/\/www.tga.gov.au\/safety\/safety-monitoring-and-information\/safety-alerts\/melanotan-ii-tanning-peptide-products-found-be-inconsistently-dosed\",\"note\":\"Official August 2026 laboratory-testing safety alert.\"},{\"title\":\"FDA Melanotan II enforcement record\",\"url\":\"https:\/\/www.fda.gov\/regulatory-information\/electronic-reading-room\/notice-opportunity-hearing-nooh-manookian-edward-8516\",\"note\":\"Official record describing Melanotan II as an unapproved new drug.\"},{\"title\":\"PubChem Melanotan II record\",\"url\":\"https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/melanotan-II\",\"note\":\"Cyclic sequence, formula and molecular weight; CID 92432.\"}]","footnotes":""},"categories":[19],"tags":[],"class_list":["post-791","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-published-study-cases"],"yoast_head":"\nMelanotan II: Human Pilot Data, Toxicity and Regulatory Status<\/title>\n<meta name=\"description\" content=\"Melanotan II has limited early human exposure data and documented harms from unregulated use. A three-person tanning pilot cannot outweigh later toxicity r\u2026\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/nhdbio.com\/de\/melanotan-ii-daten-zur-toxizitat-aus-klinischen-pilotstudien-am-menschen-fur-zulassungszwecke\/\" \/>\n<meta property=\"og:locale\" content=\"de_DE\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Melanotan II: Human Pilot Data, Toxicity and Regulatory Status\" \/>\n<meta property=\"og:description\" content=\"Melanotan II has limited early human exposure data and documented harms from unregulated use. A three-person tanning pilot cannot outweigh later toxicity r\u2026\" \/>\n<meta property=\"og:url\" content=\"https:\/\/nhdbio.com\/de\/melanotan-ii-daten-zur-toxizitat-aus-klinischen-pilotstudien-am-menschen-fur-zulassungszwecke\/\" \/>\n<meta property=\"og:site_name\" content=\"NHD\" \/>\n<meta property=\"article:published_time\" content=\"2026-09-01T17:35:05+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-09-08T07:30:41+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/09\/melanotan-ii-evidence.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1672\" \/>\n\t<meta property=\"og:image:height\" content=\"941\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/webp\" \/>\n<meta name=\"author\" content=\"NHD Technical Team\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:description\" content=\"Peptide Raw Materials and Custom Peptide Synthesis\" \/>\n<meta name=\"twitter:label1\" content=\"Verfasst von\" \/>\n\t<meta name=\"twitter:data1\" content=\"NHD Technical Team\" \/>\n\t<meta name=\"twitter:label2\" content=\"Gesch\u00e4tzte Lesezeit\" \/>\n\t<meta name=\"twitter:data2\" content=\"2\u00a0Minuten\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/melanotan-ii-human-pilot-toxicity-regulatory-evidence\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/melanotan-ii-human-pilot-toxicity-regulatory-evidence\\\/\"},\"author\":{\"name\":\"NHD Technical Team\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#\\\/schema\\\/person\\\/0ffb0dec7fda0f720073fc468fac6fc1\"},\"headline\":\"Melanotan II: Human Pilot Data, Toxicity and Regulatory Status\",\"datePublished\":\"2026-09-01T17:35:05+00:00\",\"dateModified\":\"2026-09-08T07:30:41+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/melanotan-ii-human-pilot-toxicity-regulatory-evidence\\\/\"},\"wordCount\":334,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/melanotan-ii-human-pilot-toxicity-regulatory-evidence\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/nhdbio.com\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/melanotan-ii-evidence.webp\",\"articleSection\":[\"Published Study Reviews\"],\"inLanguage\":\"de\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/nhdbio.com\\\/melanotan-ii-human-pilot-toxicity-regulatory-evidence\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/melanotan-ii-human-pilot-toxicity-regulatory-evidence\\\/\",\"url\":\"https:\\\/\\\/nhdbio.com\\\/melanotan-ii-human-pilot-toxicity-regulatory-evidence\\\/\",\"name\":\"Melanotan II: Human Pilot Data, Toxicity and Regulatory Status\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/melanotan-ii-human-pilot-toxicity-regulatory-evidence\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/melanotan-ii-human-pilot-toxicity-regulatory-evidence\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/nhdbio.com\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/melanotan-ii-evidence.webp\",\"datePublished\":\"2026-09-01T17:35:05+00:00\",\"dateModified\":\"2026-09-08T07:30:41+00:00\",\"description\":\"Melanotan II has limited early human exposure data and documented harms from unregulated use. A three-person tanning pilot cannot outweigh later toxicity r\u2026\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/melanotan-ii-human-pilot-toxicity-regulatory-evidence\\\/#breadcrumb\"},\"inLanguage\":\"de\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/nhdbio.com\\\/melanotan-ii-human-pilot-toxicity-regulatory-evidence\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"de\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/melanotan-ii-human-pilot-toxicity-regulatory-evidence\\\/#primaryimage\",\"url\":\"https:\\\/\\\/nhdbio.com\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/melanotan-ii-evidence.webp\",\"contentUrl\":\"https:\\\/\\\/nhdbio.com\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/melanotan-ii-evidence.webp\",\"width\":1672,\"height\":941,\"caption\":\"AI-generated illustration: clinical-toxicology case review\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/melanotan-ii-human-pilot-toxicity-regulatory-evidence\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/nhdbio.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Melanotan II: Human Pilot Data, Toxicity and Regulatory Status\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#website\",\"url\":\"https:\\\/\\\/nhdbio.com\\\/\",\"name\":\"NHD\",\"description\":\"Peptide Raw Materials and Custom Peptide Synthesis\",\"publisher\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/nhdbio.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"de\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#organization\",\"name\":\"NHD\",\"url\":\"https:\\\/\\\/nhdbio.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"de\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/nhdbio.com\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/codex-clipboard-354c928e-4b5b-482d-9261-02023d4c9680.png\",\"contentUrl\":\"https:\\\/\\\/nhdbio.com\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/codex-clipboard-354c928e-4b5b-482d-9261-02023d4c9680.png\",\"width\":2172,\"height\":724,\"caption\":\"NHD\"},\"image\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#\\\/schema\\\/person\\\/0ffb0dec7fda0f720073fc468fac6fc1\",\"name\":\"NHD Technical Team\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"de\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/8445618b3e2834fa0c7ae1a03a371ed002e9bf8d2cc1cd989dc4a71bb2b66110?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/8445618b3e2834fa0c7ae1a03a371ed002e9bf8d2cc1cd989dc4a71bb2b66110?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/8445618b3e2834fa0c7ae1a03a371ed002e9bf8d2cc1cd989dc4a71bb2b66110?s=96&d=mm&r=g\",\"caption\":\"NHD Technical Team\"},\"description\":\"NHD Technical Team maintains research-use catalog documentation and evidence summaries. Reviewed articles link to peer-reviewed papers, trial registries and regulatory records, retain null findings and study limitations, and distinguish published interventions from catalog materials. AI-assisted drafting may be used for structure; source links and evidence boundaries remain visible. This work is not independent peer review or medical advice.\",\"sameAs\":[\"https:\\\/\\\/nhdbio.com\"],\"url\":\"https:\\\/\\\/nhdbio.com\\\/de\\\/author\\\/qianmiao-technical-team\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Melanotan II: Daten von menschlichen Piloten, Toxizit\u00e4t und beh\u00f6rdlicher Status","description":"Melanotan II verf\u00fcgt \u00fcber begrenzte Daten zur fr\u00fchen Exposition des Menschen und dokumentierte Sch\u00e4den durch unregulierte Verwendung. Ein Br\u00e4unungspilot f\u00fcr drei Personen kann sp\u00e4tere Toxizit\u00e4tstests nicht aufwiegen \u2026","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/nhdbio.com\/de\/melanotan-ii-daten-zur-toxizitat-aus-klinischen-pilotstudien-am-menschen-fur-zulassungszwecke\/","og_locale":"de_DE","og_type":"article","og_title":"Melanotan II: Human Pilot Data, Toxicity and Regulatory Status","og_description":"Melanotan II has limited early human exposure data and documented harms from unregulated use. A three-person tanning pilot cannot outweigh later toxicity r\u2026","og_url":"https:\/\/nhdbio.com\/de\/melanotan-ii-daten-zur-toxizitat-aus-klinischen-pilotstudien-am-menschen-fur-zulassungszwecke\/","og_site_name":"NHD","article_published_time":"2026-09-01T17:35:05+00:00","article_modified_time":"2026-09-08T07:30:41+00:00","og_image":[{"width":1672,"height":941,"url":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/09\/melanotan-ii-evidence.webp","type":"image\/webp"}],"author":"NHD Technical Team","twitter_card":"summary_large_image","twitter_description":"Peptide Raw Materials and Custom Peptide Synthesis","twitter_misc":{"Verfasst von":"NHD Technical Team","Gesch\u00e4tzte Lesezeit":"2\u00a0Minuten"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/nhdbio.com\/melanotan-ii-human-pilot-toxicity-regulatory-evidence\/#article","isPartOf":{"@id":"https:\/\/nhdbio.com\/melanotan-ii-human-pilot-toxicity-regulatory-evidence\/"},"author":{"name":"NHD Technical Team","@id":"https:\/\/nhdbio.com\/#\/schema\/person\/0ffb0dec7fda0f720073fc468fac6fc1"},"headline":"Melanotan II: Human Pilot Data, Toxicity and Regulatory Status","datePublished":"2026-09-01T17:35:05+00:00","dateModified":"2026-09-08T07:30:41+00:00","mainEntityOfPage":{"@id":"https:\/\/nhdbio.com\/melanotan-ii-human-pilot-toxicity-regulatory-evidence\/"},"wordCount":334,"commentCount":0,"publisher":{"@id":"https:\/\/nhdbio.com\/#organization"},"image":{"@id":"https:\/\/nhdbio.com\/melanotan-ii-human-pilot-toxicity-regulatory-evidence\/#primaryimage"},"thumbnailUrl":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/09\/melanotan-ii-evidence.webp","articleSection":["Published Study Reviews"],"inLanguage":"de","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/nhdbio.com\/melanotan-ii-human-pilot-toxicity-regulatory-evidence\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/nhdbio.com\/melanotan-ii-human-pilot-toxicity-regulatory-evidence\/","url":"https:\/\/nhdbio.com\/melanotan-ii-human-pilot-toxicity-regulatory-evidence\/","name":"Melanotan II: Daten von menschlichen Piloten, Toxizit\u00e4t und beh\u00f6rdlicher Status","isPartOf":{"@id":"https:\/\/nhdbio.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/nhdbio.com\/melanotan-ii-human-pilot-toxicity-regulatory-evidence\/#primaryimage"},"image":{"@id":"https:\/\/nhdbio.com\/melanotan-ii-human-pilot-toxicity-regulatory-evidence\/#primaryimage"},"thumbnailUrl":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/09\/melanotan-ii-evidence.webp","datePublished":"2026-09-01T17:35:05+00:00","dateModified":"2026-09-08T07:30:41+00:00","description":"Melanotan II verf\u00fcgt \u00fcber begrenzte Daten zur fr\u00fchen Exposition des Menschen und dokumentierte Sch\u00e4den durch unregulierte Verwendung. Ein Br\u00e4unungspilot f\u00fcr drei Personen kann sp\u00e4tere Toxizit\u00e4tstests nicht aufwiegen \u2026","breadcrumb":{"@id":"https:\/\/nhdbio.com\/melanotan-ii-human-pilot-toxicity-regulatory-evidence\/#breadcrumb"},"inLanguage":"de","potentialAction":[{"@type":"ReadAction","target":["https:\/\/nhdbio.com\/melanotan-ii-human-pilot-toxicity-regulatory-evidence\/"]}]},{"@type":"ImageObject","inLanguage":"de","@id":"https:\/\/nhdbio.com\/melanotan-ii-human-pilot-toxicity-regulatory-evidence\/#primaryimage","url":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/09\/melanotan-ii-evidence.webp","contentUrl":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/09\/melanotan-ii-evidence.webp","width":1672,"height":941,"caption":"AI-generated illustration: clinical-toxicology case review"},{"@type":"BreadcrumbList","@id":"https:\/\/nhdbio.com\/melanotan-ii-human-pilot-toxicity-regulatory-evidence\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/nhdbio.com\/"},{"@type":"ListItem","position":2,"name":"Melanotan II: Human Pilot Data, Toxicity and Regulatory Status"}]},{"@type":"WebSite","@id":"https:\/\/nhdbio.com\/#website","url":"https:\/\/nhdbio.com\/","name":"NHD","description":"Peptidrohstoffe und individuelle Peptidsynthese","publisher":{"@id":"https:\/\/nhdbio.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/nhdbio.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"de"},{"@type":"Organization","@id":"https:\/\/nhdbio.com\/#organization","name":"NHD","url":"https:\/\/nhdbio.com\/","logo":{"@type":"ImageObject","inLanguage":"de","@id":"https:\/\/nhdbio.com\/#\/schema\/logo\/image\/","url":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/09\/codex-clipboard-354c928e-4b5b-482d-9261-02023d4c9680.png","contentUrl":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/09\/codex-clipboard-354c928e-4b5b-482d-9261-02023d4c9680.png","width":2172,"height":724,"caption":"NHD"},"image":{"@id":"https:\/\/nhdbio.com\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/nhdbio.com\/#\/schema\/person\/0ffb0dec7fda0f720073fc468fac6fc1","name":"NHD Technisches Team","image":{"@type":"ImageObject","inLanguage":"de","@id":"https:\/\/secure.gravatar.com\/avatar\/8445618b3e2834fa0c7ae1a03a371ed002e9bf8d2cc1cd989dc4a71bb2b66110?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/8445618b3e2834fa0c7ae1a03a371ed002e9bf8d2cc1cd989dc4a71bb2b66110?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/8445618b3e2834fa0c7ae1a03a371ed002e9bf8d2cc1cd989dc4a71bb2b66110?s=96&d=mm&r=g","caption":"NHD Technical Team"},"description":"Das technische Team von NHD verwaltet Katalogdokumentationen und Beweiszusammenfassungen f\u00fcr Forschungszwecke. Rezensierte Artikel verweisen auf von Experten begutachtete Artikel, Studienregister und beh\u00f6rdliche Aufzeichnungen, behalten Nullergebnisse und Studieneinschr\u00e4nkungen bei und unterscheiden ver\u00f6ffentlichte Interventionen von Katalogmaterialien. F\u00fcr die Strukturierung kann AI-unterst\u00fctztes Zeichnen verwendet werden; Quellenverkn\u00fcpfungen und Beweisgrenzen bleiben sichtbar. Bei dieser Arbeit handelt es sich nicht um eine unabh\u00e4ngige Begutachtung oder medizinische Beratung.","sameAs":["https:\/\/nhdbio.com"],"url":"https:\/\/nhdbio.com\/de\/author\/qianmiao-technical-team\/"}]}},"_links":{"self":[{"href":"https:\/\/nhdbio.com\/de\/wp-json\/wp\/v2\/posts\/791","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/nhdbio.com\/de\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/nhdbio.com\/de\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/nhdbio.com\/de\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/nhdbio.com\/de\/wp-json\/wp\/v2\/comments?post=791"}],"version-history":[{"count":1,"href":"https:\/\/nhdbio.com\/de\/wp-json\/wp\/v2\/posts\/791\/revisions"}],"predecessor-version":[{"id":1196,"href":"https:\/\/nhdbio.com\/de\/wp-json\/wp\/v2\/posts\/791\/revisions\/1196"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/nhdbio.com\/de\/wp-json\/wp\/v2\/media\/775"}],"wp:attachment":[{"href":"https:\/\/nhdbio.com\/de\/wp-json\/wp\/v2\/media?parent=791"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/nhdbio.com\/de\/wp-json\/wp\/v2\/categories?post=791"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/nhdbio.com\/de\/wp-json\/wp\/v2\/tags?post=791"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}